Jiu'an Medical: Announcement on the completion of cancellation of share repurchases and changes in shares
Securities code: 002432 Securities abbreviation: Jiu'an Medical Announcement number: 2025-071 Tianjin Jiu'an Medical Electronics Co., Ltd.
Announcement on the completion of cancellation of repurchased shares and changes in shares
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete.
There are no false records, misleading statements or material omissions.
Special tips:
The number of repurchased shares canceled this time is 9,771,882 shares, accounting for 2.06% of the company’s total share capital before cancellation. After the cancellation is completed, the company's total share capital will be changed from 474,666,672 shares to 464,894,790 shares.
After review and confirmation by the Shenzhen Branch of China Securities Depository and Clearing Co., Ltd., the cancellation of the company’s share repurchase has been completed recently.
1. Approval, implementation and change of use of this share repurchase
The company held the fifth meeting of the sixth board of directors on August 29, 2023, and reviewed and approved the "Proposal on the Company's Share Repurchase Plan". The total amount of funds for this repurchase shall not be less than 500 million yuan (inclusive) and not exceed 1 million yuan (inclusive). For details, please refer to the "Announcement on the Plan to Repurchase the Company's Shares" disclosed by the company on cninfo.com (announcement number: 2023-044).
The above-mentioned share repurchase plan has been completed on November 17, 2023. The company has repurchased a total of 27,164,101 shares through a special securities account for repurchase through centralized bidding transactions, accounting for 27,164,101 shares of the company at that time. 5.57% of the total share capital, the highest transaction price was 37.99 yuan/share, the lowest transaction price was 35.53 yuan/share, and the total transaction amount was RMB 999,996,846.14 (including transaction fees, etc.). For details, please refer to the "Announcement on the Completion of the Company's Share Repurchase and Changes in Shares" disclosed by the company on cninfo.com (announcement number: 2023-071).
The company held the 25th meeting of the sixth board of directors on September 5, 2025, and reviewed and approved the "Proposal on Changing the Use and Cancellation of Partial Repurchase Shares". In order to actively maintain the company's market value and enhance shareholder returns of listed companies, the board of directors agreed to transfer the After the implementation of the share repurchase, the purpose of the 9,771,882 shares deposited in the special repurchase account that was originally planned to be used to maintain the company's value and shareholders' rights and be reduced through centralized bidding transactions was changed to "used for cancellation and reduction of the company's registered capital." On September 22, 2025, the above proposal was reviewed and approved by the company's third extraordinary shareholders' meeting in 2025. For details, please refer to the "Announcement on Changing the Use of Partial Repurchase Shares and Cancellation and Reduction of Registered Capital" disclosed by the company on cninfo.com (announcement number: 2025-063).
2. Cancellation of shares repurchased this time
The company has recently completed the cancellation of 9,771,882 repurchased shares at the Shenzhen Branch of China Securities Depository and Clearing Co., Ltd. The number, completion date and cancellation period of the shares repurchased this time comply with the requirements of laws and regulations related to the cancellation of repurchased shares.
3. Changes in equity structure after cancellation of shares repurchased
The number of shares used by the company to reduce registered capital this time is 9,771,882 shares. After the cancellation, the total number of the company's shares changed from 474,666,672 shares to 464,894,790 shares. The company's equity distribution still meets the listing conditions and the company's listing status has not been changed. The specific changes in shareholding structure are as follows:
Before this cancellation After this cancellation
Share type
Number of shares (shares) Ratio Number of shares (shares) Ratio
Shares subject to sales restrictions 26,566,133.00 5.60% 26,566,133.00 5.71%
Shares without selling restrictions 448,100,539.00 94.40% 438,328,657.00 94.29%
Total share capital 474,666,672.00 100.00% 464,894,790.00 100.00%
4. The impact of the cancellation of this repurchase of shares on the company
This cancelation and repurchase of shares was carried out in accordance with the provisions of relevant laws, regulations and normative documents and in conjunction with the company's actual situation. It will not have a significant impact on the company's financial status, operating results and future development. It will not lead to changes in the company's controlling shareholders and actual controllers, and will not harm the interests of the company and all shareholders, especially small and medium-sized shareholders.
5. Arrangements for follow-up matters
After the cancellation of the repurchased shares is completed, the company will handle relevant matters such as industrial and commercial change registration and articles of association filing in a timely manner in accordance with relevant laws and regulations, and perform information disclosure obligations in a timely manner.
Announcement is hereby made.
Board of Directors of Tianjin Jiuan Medical Electronics Co., Ltd.
September 30, 2025